Phase I Clinical Study of HRS-2189 in the Treatment of Patients With Advanced Malignant Tumors
Clinical trial NCT05851092 · UNKNOWN
Trial details
- NCT number
- NCT05851092
- Sponsor
- Shandong Suncadia Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-26
- Primary completion
- 2025-12-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.